The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Opioid use disorder (OUD), which contributes to the ongoing overdose crisis claiming over 21 lives across Canada a day, is even more severe within correctional settings. In North America, OUD is a ...

RICHMOND, Va., March 31, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc., (Nasdaq: INDV) today announced findings from a new cost impact model published in The Journal of Current Medical ...

Extended-release buprenorphine (BUP-XR) increased the number of opioid-free days compared with methadone or sublingual buprenorphine (MET/BUP-SL) in adults with moderate-to-severe opioid use disorder ...

More than 15 years ago, Yale's Gail D'Onofrio started studying the effectiveness of sublingual (under-the-tongue) buprenorphine for treatment of opioid use disorder (OUD) in the emergency department.

Pregnant patients with opioid use disorder (OUD) who received subcutaneous extended-release buprenorphine had higher rates of abstinence from illegal opioids than those who received the sublingual ...

Leads to superior rates of illicit opioid abstinence and improved outcomes compared with sublingual buprenorphine. HealthDay News — Injectable, extended-release buprenorphine is safe and effective in ...

About The Study: In this multicenter randomized clinical trial, rapid induction had higher retention than standard induction overall and in patients who tested positive for fentanyl through ...

Extended-release 7-day injectable buprenorphine was safe and tolerable for most patients who had minimal-to-mild opioid withdrawal, a nonrandomized trial found. Among 100 adult patients with ...

CLEVELAND, Ohio — A longer-acting medication may be more effective at helping pregnant women with opioid use disorder avoid illegal drugs, suggests new research from the University of Cincinnati.

Rapid initiation Protocol: Healthcare providers can now initiate treatment with SUBLOCADE after a single dose of transmucosal buprenorphine and a one-hour observation period to confirm ...